Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis

Min Chen, Liang-zhou Chen, Lin Xu, Jin-song Zhang, Xue Song Department of General Surgery, Xiamen Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Xiamen 361009, China Background: Neoadjuvant chemoradiotherapy (CRT) prior to surgery is a standard therapy f...

Full description

Bibliographic Details
Main Authors: Chen M, Chen L, Xu L, Zhang J, Song X
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/neoadjuvant-chemoradiation-for-locally-advanced-rectal-cancer-a-system-peer-reviewed-article-CMAR
_version_ 1811218334377574400
author Chen M
Chen L
Xu L
Zhang J
Song X
author_facet Chen M
Chen L
Xu L
Zhang J
Song X
author_sort Chen M
collection DOAJ
description Min Chen, Liang-zhou Chen, Lin Xu, Jin-song Zhang, Xue Song Department of General Surgery, Xiamen Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Xiamen 361009, China Background: Neoadjuvant chemoradiotherapy (CRT) prior to surgery is a standard therapy for locally advanced rectal cancer, but the optimum regime is not conclusive. This meta-analysis evaluated various CRT regimens with regard to the rate of pathologic complete response (pCR) and toxic effects of grade ≥3.Methods: The databases PubMed, Cochrane Library, and Embase were searched for randomized controlled trials (RCTs) that compared neoadjuvant CRT regimes for treating patients with locally advanced rectal cancer, published before 28 December 2017. The primary end points were pCR and toxic effects. A network meta-analysis was applied.Results: Fourteen RCTs (with 5,599 participants) involving the following eight regimens were included: fluorouracil (5FU) alone, or 5FU with oxaliplatin (OXA), cisplatin, or irinotecan (CPT-11); capecitabine (CAP) alone, or CAP with OXA or CPT-11; and CPT-11 with combined tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate. The rate of pCR associated with CAP + OXA was significantly higher compared with 5FU alone; there were no significant differences among the other regimens. The toxicity of 5FU + OXA or CAP + OXA was significantly worse than that of 5FU alone or CAP alone. CAP + OXA and CAP were ranked, respectively, the most and second most effective regimens in terms of pCR rate. 5FU alone and CAP alone likely had the lowest and second lowest toxicity, respectively.Conclusion: Among the currently available CRT regimens for locally advanced rectal cancer, this meta-analysis indicated that CAP + OXA provides the superior clinical results. Adding OXA to 5FU or CAP significantly increases toxicity. Keywords: network meta-analysis, locally advanced rectal cancer, neoadjuvant, chemoradiation
first_indexed 2024-04-12T07:08:56Z
format Article
id doaj.art-00d0fd2263cc404682974d47a4eac372
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-04-12T07:08:56Z
publishDate 2019-01-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-00d0fd2263cc404682974d47a4eac3722022-12-22T03:42:41ZengDove Medical PressCancer Management and Research1179-13222019-01-01Volume 1174175843585Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysisChen MChen LXu LZhang JSong XMin Chen, Liang-zhou Chen, Lin Xu, Jin-song Zhang, Xue Song Department of General Surgery, Xiamen Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Xiamen 361009, China Background: Neoadjuvant chemoradiotherapy (CRT) prior to surgery is a standard therapy for locally advanced rectal cancer, but the optimum regime is not conclusive. This meta-analysis evaluated various CRT regimens with regard to the rate of pathologic complete response (pCR) and toxic effects of grade ≥3.Methods: The databases PubMed, Cochrane Library, and Embase were searched for randomized controlled trials (RCTs) that compared neoadjuvant CRT regimes for treating patients with locally advanced rectal cancer, published before 28 December 2017. The primary end points were pCR and toxic effects. A network meta-analysis was applied.Results: Fourteen RCTs (with 5,599 participants) involving the following eight regimens were included: fluorouracil (5FU) alone, or 5FU with oxaliplatin (OXA), cisplatin, or irinotecan (CPT-11); capecitabine (CAP) alone, or CAP with OXA or CPT-11; and CPT-11 with combined tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate. The rate of pCR associated with CAP + OXA was significantly higher compared with 5FU alone; there were no significant differences among the other regimens. The toxicity of 5FU + OXA or CAP + OXA was significantly worse than that of 5FU alone or CAP alone. CAP + OXA and CAP were ranked, respectively, the most and second most effective regimens in terms of pCR rate. 5FU alone and CAP alone likely had the lowest and second lowest toxicity, respectively.Conclusion: Among the currently available CRT regimens for locally advanced rectal cancer, this meta-analysis indicated that CAP + OXA provides the superior clinical results. Adding OXA to 5FU or CAP significantly increases toxicity. Keywords: network meta-analysis, locally advanced rectal cancer, neoadjuvant, chemoradiationhttps://www.dovepress.com/neoadjuvant-chemoradiation-for-locally-advanced-rectal-cancer-a-system-peer-reviewed-article-CMARnetwork meta-analysislocally advanced rectal cancerneoadjuvantchemoradiation
spellingShingle Chen M
Chen L
Xu L
Zhang J
Song X
Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
Cancer Management and Research
network meta-analysis
locally advanced rectal cancer
neoadjuvant
chemoradiation
title Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
title_full Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
title_fullStr Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
title_full_unstemmed Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
title_short Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
title_sort neoadjuvant chemoradiation for locally advanced rectal cancer a systematic review of the literature with network meta analysis
topic network meta-analysis
locally advanced rectal cancer
neoadjuvant
chemoradiation
url https://www.dovepress.com/neoadjuvant-chemoradiation-for-locally-advanced-rectal-cancer-a-system-peer-reviewed-article-CMAR
work_keys_str_mv AT chenm neoadjuvantchemoradiationforlocallyadvancedrectalcancerasystematicreviewoftheliteraturewithnetworkmetaanalysis
AT chenl neoadjuvantchemoradiationforlocallyadvancedrectalcancerasystematicreviewoftheliteraturewithnetworkmetaanalysis
AT xul neoadjuvantchemoradiationforlocallyadvancedrectalcancerasystematicreviewoftheliteraturewithnetworkmetaanalysis
AT zhangj neoadjuvantchemoradiationforlocallyadvancedrectalcancerasystematicreviewoftheliteraturewithnetworkmetaanalysis
AT songx neoadjuvantchemoradiationforlocallyadvancedrectalcancerasystematicreviewoftheliteraturewithnetworkmetaanalysis